09/25/2023 6:37 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:54 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:55 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 7:55 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 6:37 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 6:38 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/01/2023 4:31 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/29/2023 4:14 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 4:28 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 6:10 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/04/2023 3:42 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2023 7:32 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2023 3:47 PM | FibroGen (Subject) MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
07/19/2023 6:01 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 7:28 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2023 3:46 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023 6:36 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 3:27 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 8:05 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 8:53 PM | FibroGen (Subject) Wettig Thane (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023 5:32 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4/A | |
06/15/2023 7:17 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 5:15 PM | Chung Christine (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023 6:52 PM | FibroGen (Issuer) Henderson Jeffrey William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:53 PM | EDWARDS JEFFREY L (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:53 PM | FibroGen (Issuer) Lema Gerald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:54 PM | FibroGen (Issuer) Ho Maykin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:54 PM | Blaug Suzanne (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:55 PM | Brennan Aoife (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:56 PM | Cravatt Benjamin (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 7:10 PM | Cravatt Benjamin (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023 7:11 PM | EDWARDS JEFFREY L (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023 7:14 PM | Blaug Suzanne (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023 7:17 PM | Brennan Aoife (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023 6:51 PM | FibroGen (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:38 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:39 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:39 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:10 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:12 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 6:49 PM | FibroGen (Subject) Graham Juan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
06/08/2023 4:51 PM | FibroGen (Subject) Ho Maykin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023 4:51 PM | FibroGen (Subject) Henderson Jeffrey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 8:51 PM | FibroGen (Subject) Graham Juan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 8:31 PM | Chung Christine (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 8:36 PM | Eisner Mark (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 8:41 PM | FibroGen (Subject) Wettig Thane (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 9:34 AM | FibroGen (Subject) Schoeneck James A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 8:00 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 7:53 PM | Eisner Mark (Reporting) FibroGen (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023 8:00 AM | FibroGen (Filer)
| Form DEFA14A | |
05/18/2023 6:35 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2023 3:59 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/06/2023 3:32 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2023 4:05 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/24/2023 7:27 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/23/2023 3:50 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4/A | |
03/10/2023 8:53 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2023 8:54 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2023 8:55 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2023 8:55 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2023 8:58 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2023 3:29 PM | FibroGen (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/23/2023 7:39 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2023 7:41 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2023 7:42 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2023 7:29 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2023 7:38 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/17/2023 4:26 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 5/A | |
02/08/2023 9:05 AM | FibroGen (Subject) FIRST TRUST PORTFOLIOS LP (Filed by)
| Form SC 13G/A | |
02/06/2023 11:37 AM | BlackRock Inc. (Filed by) FibroGen (Subject)
| Form SC 13G/A | |
02/02/2023 4:22 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
01/10/2023 3:46 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2023 5:35 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4/A | |
01/04/2023 5:33 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4/A | |
12/28/2022 5:38 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2022 4:23 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2022 4:23 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4/A | |
12/14/2022 8:55 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2022 6:19 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2022 6:21 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2022 6:22 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2022 4:41 PM | Eisner Mark (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2022 3:06 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2022 4:06 PM | Conterno Enrique A (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2022 4:30 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |